Insider buys and sells (Form 4)
Kiniksa Pharmaceuticals International, plc insiders: buys and sells · KNSA
Directors, officers and 10%+ shareholders must report every purchase and sale of their company's stock to the SEC within two business days. Transactions filed between 2026-10-30 and 2026-11-03. All filings on SEC EDGAR →
- Bought
- $0
- Sold
- $62,777,251
- Buys
- 0
- Sells
- 47
The 47 transactions
| Date | Who | Role | Transaction | Shares | Price | Amount |
|---|---|---|---|---|---|---|
| 2026-11-03 | Patel Sanj K | CHAIRMAN & CEO | sell | 145.708 | 93,53 | $13,628,069 |
| 2026-11-03 | Patel Sanj K | CHAIRMAN & CEO | sell | 68.664 | 92,70 | $6,365,153 |
| 2026-11-03 | Patel Sanj K | CHAIRMAN & CEO | sell | 4.584 | 94,25 | $432,042 |
| 2026-11-03 | Patel Sanj K | CHAIRMAN & CEO | sell | 1.214 | 90,77 | $110,195 |
| 2026-11-02 | Patel Sanj K | CHAIRMAN & CEO | sell | 38.364 | 91,03 | $3,492,275 |
| 2026-11-02 | Patel Sanj K | CHAIRMAN & CEO | sell | 26.781 | 93,06 | $2,492,240 |
| 2026-11-02 | Patel Sanj K | CHAIRMAN & CEO | sell | 24.188 | 91,83 | $2,221,184 |
| 2026-11-02 | Paolini John F. | CHIEF MEDICAL OFFICER | sell | 16.810 | 93,42 | $1,570,390 |
| 2026-11-02 | Ragosa Mark | CHIEF FINANCIAL OFFICER | sell | 14.027 | 91,40 | $1,282,068 |
| 2026-11-02 | Ragosa Mark | CHIEF FINANCIAL OFFICER | sell | 12.034 | 93,13 | $1,120,726 |
| 2026-11-02 | Moat Ross | CHIEF OPERATING OFFICER | sell | 11.642 | 93,15 | $1,084,452 |
| 2026-11-02 | Ragosa Mark | CHIEF FINANCIAL OFFICER | sell | 10.502 | 92,03 | $966,499 |
| 2026-11-02 | Moat Ross | CHIEF OPERATING OFFICER | sell | 8.932 | 92,05 | $822,191 |
| 2026-11-02 | Moat Ross | CHIEF OPERATING OFFICER | sell | 6.681 | 91,23 | $609,508 |
| 2026-11-02 | Paolini John F. | CHIEF MEDICAL OFFICER | sell | 899 | 92,37 | $83,041 |
| 2026-11-02 | Moat Ross | CHIEF OPERATING OFFICER | sell | 722 | 94,05 | $67,904 |
| 2026-11-02 | Paolini John F. | CHIEF MEDICAL OFFICER | sell | 704 | 94,09 | $66,239 |
| 2026-11-02 | Ragosa Mark | CHIEF FINANCIAL OFFICER | sell | 220 | 94,01 | $20,682 |
| 2026-11-02 | Patel Sanj K | CHAIRMAN & CEO | sell | 100 | 93,97 | $9,397 |
| 2026-10-30 | Paolini John F. | CHIEF MEDICAL OFFICER | sell | 41.789 | 92,02 | $3,845,424 |
| 2026-10-30 | Patel Sanj K | CHAIRMAN & CEO | sell | 41.169 | 92,01 | $3,787,960 |
| 2026-10-30 | Moat Ross | CHIEF OPERATING OFFICER | sell | 37.775 | 92,00 | $3,475,300 |
| 2026-10-30 | Patel Sanj K | CHAIRMAN & CEO | sell | 18.685 | 92,77 | $1,733,407 |
| 2026-10-30 | Paolini John F. | CHIEF MEDICAL OFFICER | sell | 16.056 | 92,85 | $1,490,800 |
| 2026-10-30 | Patel Sanj K | CHAIRMAN & CEO | sell | 15.903 | 93,62 | $1,488,839 |
| 2026-10-30 | Moat Ross | CHIEF OPERATING OFFICER | sell | 15.114 | 92,81 | $1,402,730 |
| 2026-10-30 | Megna Michael R | CHIEF ACCOUNTING OFFICER | sell | 9.508 | 94,20 | $895,654 |
| 2026-10-30 | Patel Sanj K | CHAIRMAN & CEO | sell | 8.888 | 94,72 | $841,871 |
| 2026-10-30 | Moat Ross | CHIEF OPERATING OFFICER | sell | 8.430 | 93,97 | $792,167 |
| 2026-10-30 | Paolini John F. | CHIEF MEDICAL OFFICER | sell | 6.841 | 93,91 | $642,438 |
| 2026-10-30 | Megna Michael R | CHIEF ACCOUNTING OFFICER | sell | 6.831 | 92,77 | $633,712 |
| 2026-10-30 | Moat Ross | CHIEF OPERATING OFFICER | sell | 6.282 | 94,92 | $596,287 |
| 2026-10-30 | Megna Michael R | CHIEF ACCOUNTING OFFICER | sell | 6.030 | 91,87 | $553,976 |
| 2026-10-30 | Megna Michael R | CHIEF ACCOUNTING OFFICER | sell | 5.350 | 97,74 | $522,909 |
| 2026-10-30 | Paolini John F. | CHIEF MEDICAL OFFICER | sell | 4.821 | 94,86 | $457,320 |
| 2026-10-30 | Patel Sanj K | CHAIRMAN & CEO | sell | 4.490 | 95,97 | $430,905 |
| 2026-10-30 | Paolini John F. | CHIEF MEDICAL OFFICER | sell | 4.000 | 95,97 | $383,880 |
| 2026-10-30 | Moat Ross | CHIEF OPERATING OFFICER | sell | 3.672 | 96,03 | $352,622 |
| 2026-10-30 | Megna Michael R | CHIEF ACCOUNTING OFFICER | sell | 3.705 | 94,86 | $351,456 |
| 2026-10-30 | Megna Michael R | CHIEF ACCOUNTING OFFICER | sell | 3.145 | 96,08 | $302,172 |
| 2026-10-30 | Moat Ross | CHIEF OPERATING OFFICER | sell | 2.575 | 97,76 | $251,732 |
| 2026-10-30 | Patel Sanj K | CHAIRMAN & CEO | sell | 2.316 | 97,34 | $225,439 |
| 2026-10-30 | Paolini John F. | CHIEF MEDICAL OFFICER | sell | 2.155 | 97,77 | $210,694 |
| 2026-10-30 | Paolini John F. | CHIEF MEDICAL OFFICER | sell | 1.925 | 97,06 | $186,840 |
| 2026-10-30 | Moat Ross | CHIEF OPERATING OFFICER | sell | 1.760 | 97,10 | $170,896 |
| 2026-10-30 | Megna Michael R | CHIEF ACCOUNTING OFFICER | sell | 1.691 | 97,11 | $164,213 |
| 2026-10-30 | Patel Sanj K | CHAIRMAN & CEO | sell | 1.440 | 98,16 | $141,350 |
How to read these transactions
There are 47 filed transactions for Kiniksa Pharmaceuticals International, plc (KNSA) between 2026-10-30 and 2026-11-03. They were made by 5 different people. Open-market buys: 0, for $0. Sells: 47, for $62,777,251.
Each transaction comes from a Form 4, the filing the person submits to the SEC. In the table, each row is one transaction: the date, who made it and their role, whether it is a buy or a sell, the number of shares, the declared price per share and the total amount.
Open-market buys are the ones people watch most, because whoever makes them puts in their own money. Sells say less: they often respond to taxes, diversification or sale plans scheduled in advance. A single transaction does not say much either; what people look at is whether they repeat, from how many people and for what amount.
Other companies with insider trades
Kinetik Holdings Inc. (KNTK) · Kodiak Sciences Inc. (KOD) · Karyopharm Therapeutics Inc. (KPTI) · KORU Medical Systems, Inc. (KRMD) · Kornit Digital Ltd. (KRNT) · Korro Bio, Inc. (KRRO) · Karat Packaging Inc. (KRT) · Kinetic Seas Inc. (KSEZ)
Public SEC data (EDGAR), Form 4. Open-market buys and sells only: option exercises and stock received as pay are left out. This is not investment advice.
Follow them next to your own portfolio
In Arvenyx you see these portfolios, insider buys and your own portfolio, across all your brokers, in one place.
Create a free account